Clinical Trial Update: Administration of Methylprednisolone for Prevention of Ovarian Hyper Stimulation Syndrome [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating methylprednisolone to prevent ovarian hyperstimulation syndrome has completed, sponsored by Royan Institute.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Hyperstimulation Syndrome

Drugs mentioned

• METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: Royan Institute | Conditions: Ovarian Hyperstimulation Syndrome | Phase 1, Phase 2 | Status: COMPLETED